Business Context and Reporting Period
This Form 8-K filing by Bit Digital, Inc. (BTBT) reports corporate governance changes and executive appointments effective December 2025. The report date is December 7, 2025, with events occurring through December 11, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel changes and related compensation arrangements.
Material Changes
- Board Resignation: Xiashu ("Bill") Xiong resigned from the Board of Directors, effective January 1, 2026.
- Role Transition: Zhaohui Deng transitioned from Chairman of the Board to an independent director, effective December 9, 2025.
- New Director Appointment: The Board elected Ms. Amanda Cassatt to serve a one-year term commencing January 1, 2026.
- Compensation Award: Ms. Cassatt was awarded 84,388 Restricted Share Units (RSUs) with a market value of $200,000, vesting 50% immediately, 25% in three months, and 25% in six months.
- Related Party Transaction: The Company is paying Serotonin Inc., a firm controlled by Ms. Cassatt, a monthly retainer of $30,000 under a consulting agreement expiring December 18, 2025, with automatic renewal terms.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of general business risks. The primary disclosure relates to the potential conflict of interest regarding the consulting agreement with Serotonin Inc., where the new director is a principal. The agreement includes a non-solicitation provision for one year following termination.
Investor Verification Checklist
- Verify the vesting schedule and total value of the $200,000 RSU grant to Amanda Cassatt.
- Review the terms of the consulting agreement with Serotonin Inc., specifically the $30,000 monthly fee and renewal conditions.
- Confirm the effective dates of the Board composition changes (Xiong's departure and Cassatt's appointment).
- Assess the scope of services provided by Serotonin Inc. to ensure alignment with the Company's strategic needs.